TY - JOUR
T1 - Coincident Regulation of PLCb Signaling by Gq-Coupled and l-Opioid Receptors Opposes Opioid-Mediated Antinociception
AU - Sanchez, Gissell A.
AU - Jutkiewicz, Emily M.
AU - Ingram, Susan
AU - Smrcka, Alan V.
N1 - Funding Information:
This work was supported by National Institutes of Health Institute of Drug Abuse [Grants R01DA048625; R01DA048625-S1]. No author has an actual or perceived conflict of interest with the contents of this article. 1Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (G.A.S., E.M.J., A.V.S.) and Department of Neurologic Surgery, Oregon Health Sciences University, Portland, Oregon (S.I.) 2Current affiliation: Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado. dx.doi.org/10.1124/molpharm.122.000541.
Publisher Copyright:
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Pain management is an important problem worldwide. The current frontline approach for pain management is the use of opioid analgesics. The primary analgesic target of opioids is the l-opioid receptor (MOR). Deletion of phospholipase Cb3 (PLCb3) or selective inhibition of Gbc regulation of PLCb3 enhances the potency of the antinociceptive effects of morphine suggesting a novel strategy for achieving opioid-sparing effects. Here we investigated a potential mechanism for regulation of PLC signaling downstream of MOR in human embryonic kidney 293 cells and found that MOR alone could not stimulate PLC but rather required a coincident signal from a Gq-coupled receptor. Knockout of PLCb3 or pharmacological inhibition of its upstream regulators, Gbc or Gq, ex vivo in periaqueductal gray slices increased the potency of the selective MOR agonist [D-Ala2, N-Me-Phe4, Gly5-ol]enkephalin acetate salt in inhibiting presynaptic GABA release. Finally, inhibition of Gq- G protein-coupled receptor coupling in mice enhanced the antinociceptive effects of morphine. These data support a model where Gq and Gbc-dependent signaling cooperatively regulate PLC activation to decrease MOR-dependent antinociceptive potency. Ultimately, this could lead to identification of new non-MOR targets that would allow for lower-dose utilization of opioid analgesics.
AB - Pain management is an important problem worldwide. The current frontline approach for pain management is the use of opioid analgesics. The primary analgesic target of opioids is the l-opioid receptor (MOR). Deletion of phospholipase Cb3 (PLCb3) or selective inhibition of Gbc regulation of PLCb3 enhances the potency of the antinociceptive effects of morphine suggesting a novel strategy for achieving opioid-sparing effects. Here we investigated a potential mechanism for regulation of PLC signaling downstream of MOR in human embryonic kidney 293 cells and found that MOR alone could not stimulate PLC but rather required a coincident signal from a Gq-coupled receptor. Knockout of PLCb3 or pharmacological inhibition of its upstream regulators, Gbc or Gq, ex vivo in periaqueductal gray slices increased the potency of the selective MOR agonist [D-Ala2, N-Me-Phe4, Gly5-ol]enkephalin acetate salt in inhibiting presynaptic GABA release. Finally, inhibition of Gq- G protein-coupled receptor coupling in mice enhanced the antinociceptive effects of morphine. These data support a model where Gq and Gbc-dependent signaling cooperatively regulate PLC activation to decrease MOR-dependent antinociceptive potency. Ultimately, this could lead to identification of new non-MOR targets that would allow for lower-dose utilization of opioid analgesics.
UR - http://www.scopus.com/inward/record.url?scp=85141935963&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141935963&partnerID=8YFLogxK
U2 - 10.1124/molpharm.122.000541
DO - 10.1124/molpharm.122.000541
M3 - Article
C2 - 36116788
AN - SCOPUS:85141935963
SN - 0026-895X
VL - 102
SP - 269
EP - 279
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 6
ER -